Onesource Specialty Pharma Limited
Motilal Oswal Mutual Fund increased its stake in Onesource Specialty Pharma Limited from 4.99% to 7.06%, buying an additional 23,69,500 shares. This transaction increased their total holdings to 80,94,694 shares, worth ₹1272.06 Cr at ₹1571.30 apiece. This deal crossed the 5% disclosure threshold.
A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.
AMC arm of Motilal Oswal Financial Services, founded on the belief in long-term buy-and-hold quality investing. Manages over Rs 1.5 lakh crore. Famous for the QGLP (Quality, Growth, Longevity, Price) investment framework and concentrated portfolios with very low churn. Flagship Motilal Oswal Midcap and Motilal Oswal Flexi Cap funds reflect deep conviction positioning with 15-25 stock portfolios.